Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In patients with moderate TBI, the 3-month Glasgow Coma Scale score significantly differed between vitamin D groups (P < .001).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D deficiency is associated with worse neurological outcomes in moderate and severe traumatic brain injury: A prospective observational cohort study

Source: Article title.

To maximize sample size and capture the breadth of clinical presentations, participants were recruited using an availability-based, consecutive sampling approach during routine visits to the aforementioned centers.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D deficiency is associated with worse neurological outcomes in moderate and severe traumatic brain injury: A prospective observational cohort study

Cohort study · Medicine · 2025

Original publication title

Vitamin D deficiency is associated with worse neurological outcomes in moderate and severe traumatic brain injury: A prospective observational cohort study

Mehdi Mahmoodkhani; Arvin Rahimi; Arvin Naeimi; Sepehr Aghajanian; Anita Naeimi

Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Vitamin D deficiency is correlated with neuroinflammation and neurocognitive defects. The present study investigated the relationship between the serum level of vitamin D and intensive care unit (ICU) length of stay, nosocomial infection, Acute Physiology and Chronic Health Evaluation II (APACHE II) score during hospitalization, and Glasgow Outcome Scale-Extended (GOSE) at 3 months in patients with moderate and severe traumatic brain injury (TBI). This prospective observational cohort study included 300 moderate-severe TBI patients admitted between May 2021 and May 2022.

Demographic information and clinical characteristics of patients were collected prospectively. Serum vitamin D level (25-hydroxyvitamin D) was measured on admission and repeated 7 days after admission, as well as at the 3-month follow-up visit after admission. Vitamin D status was dichotomized into deficient (<20 ng/mL) and sufficient (≥20 ng/mL) groups. During a 90-day clinical follow-up, the GOSE, Glasgow Coma Scale, and mortality were assessed. The primary outcome was GOSE at 3 months after admission, and secondary outcomes were ICU length of stay, nosocomial infection, and APACHE II scores.

Three hundred patients with a mean age of 34.98 ± 14.75 years were included. There were 222 (74%) patients with moderate TBI and 78 (26%) with severe TBI. In patients with moderate TBI, the 3-month Glasgow Coma Scale score significantly differed between vitamin D groups (P < .001). There was no difference in 3-month mortality between the groups. Baseline vitamin D measurements were not associated with ICU length of stay (P = .828), nosocomial infection (P = .077), and APACHE II score (P = .219).

Vitamin D deficiency (<20 ng/mL) throughout the measurements was associated with lower GOSE scores (proportional odds ratio = 0.62, confidence interval: 0.40 to 0.93, P = .022). The results of this study suggest that vitamin D deficiency is associated with poorer neurological outcomes, as assessed by the GOSE, at 3 months. The potential role of vitamin D status as a prognostic marker and the effect of its supplementation in TBI patients should be investigated in future large-scale randomized controlled studies.

Authors’ abstract

Vitamin D deficiency is correlated with neuroinflammation and neurocognitive defects. The present study investigated the relationship between the serum level of vitamin D and intensive care unit (ICU) length of stay, nosocomial infection, Acute Physiology and Chronic Health Evaluation II (APACHE II) score during hospitalization, and Glasgow Outcome Scale-Extended (GOSE) at 3 months in patients with moderate and severe traumatic brain injury (TBI). This prospective observational cohort study included 300 moderate-severe TBI patients admitted between May 2021 and May 2022.

Demographic information and clinical characteristics of patients were collected prospectively. Serum vitamin D level (25-hydroxyvitamin D) was measured on admission and repeated 7 days after admission, as well as at the 3-month follow-up visit after admission. Vitamin D status was dichotomized into deficient (<20 ng/mL) and sufficient (≥20 ng/mL) groups. During a 90-day clinical follow-up, the GOSE, Glasgow Coma Scale, and mortality were assessed. The primary outcome was GOSE at 3 months after admission, and secondary outcomes were ICU length of stay, nosocomial infection, and APACHE II scores.

Three hundred patients with a mean age of 34.98 ± 14.75 years were included. There were 222 (74%) patients with moderate TBI and 78 (26%) with severe TBI. In patients with moderate TBI, the 3-month Glasgow Coma Scale score significantly differed between vitamin D groups (P < .001). There was no difference in 3-month mortality between the groups. Baseline vitamin D measurements were not associated with ICU length of stay (P = .828), nosocomial infection (P = .077), and APACHE II score (P = .219).

Vitamin D deficiency (<20 ng/mL) throughout the measurements was associated with lower GOSE scores (proportional odds ratio = 0.62, confidence interval: 0.40 to 0.93, P = .022). The results of this study suggest that vitamin D deficiency is associated with poorer neurological outcomes, as assessed by the GOSE, at 3 months. The potential role of vitamin D status as a prognostic marker and the effect of its supplementation in TBI patients should be investigated in future large-scale randomized controlled studies.

Publication and source details

Original title: Vitamin D deficiency is associated with worse neurological outcomes in moderate and severe traumatic brain injury: A prospective observational cohort study

Mehdi Mahmoodkhani; Arvin Rahimi; Arvin Naeimi; Sepehr Aghajanian; Anita Naeimi

Medicine · 2025

* Correspondence: Arvin Naeimi, Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht 41446-66949, Iran (e-mail: arvin.naeimi@gmail.com).Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:57:51.516829+00:00

DOI: 10.1097/md.0000000000045202 · PMC12537106